Tools & Wizards About Us
drugresearcher.com screenshot

Report Summary

  • 22

    Performance

    Renders faster than
    40% of other websites

  • 100

    Accessibility

    Visual factors better than
    that of 97% of websites

  • 75

    Best Practices

    More advanced features
    available than in
    35% of websites

  • 93

    SEO

    Google-friendlier than
    83% of websites

drugresearcher.com

Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Page Load Speed

1.7 sec in total

First Response

191 ms

Resources Loaded

1.1 sec

Page Rendered

361 ms

drugresearcher.com screenshot

About Website

Visit drugresearcher.com now to see the best up-to-date Drug Research Er content and also check out these interesting facts you probably never knew about drugresearcher.com

Daily news on pharmaceutical outsourcing. Free access to news on pharmaceutical supply, pharmaceutical manufacturing, contract research and pharmaceutical services

Visit drugresearcher.com

Key Findings

We analyzed Drugresearcher.com page load time and found that the first response time was 191 ms and then it took 1.5 sec to load all DOM resources and completely render a web page. This is quite a good result, as only 30% of websites can load faster.

Performance Metrics

drugresearcher.com performance score

22

Measured Metrics

name

value

score

weighting

FCP (First Contentful Paint)

Value4.0 s

24/100

10%

LCP (Largest Contentful Paint)

Value11.7 s

0/100

25%

SI (Speed Index)

Value7.6 s

25/100

10%

TBT (Total Blocking Time)

Value2,380 ms

5/100

30%

CLS (Cumulative Layout Shift)

Value0

100/100

15%

TTI (Time to Interactive)

Value17.8 s

4/100

10%

Network Requests Diagram

drugresearcher.com

191 ms

www.outsourcing-pharma.com

47 ms

OtAutoBlock.js

64 ms

otSDKStub.js

76 ms

css2

69 ms

Our browser made a total of 82 requests to load all elements on the main page. We found that 1% of them (1 request) were addressed to the original Drugresearcher.com, 79% (65 requests) were made to Outsourcing-pharma.com and 5% (4 requests) were made to Fonts.gstatic.com. The less responsive or slowest element that took the longest time to load (759 ms) relates to the external source Mediaresources.wrbm.com.

Page Optimization Overview & Recommendations

Page size can be reduced by 620.0 kB (37%)

Content Size

1.7 MB

After Optimization

1.1 MB

  • HTML
  • Images
  • JavaScript
  • CSS

In fact, the total size of Drugresearcher.com main page is 1.7 MB. This result falls beyond the top 1M of websites and identifies a large and not optimized web page that may take ages to load. 70% of websites need less resources to load. Images take 851.5 kB which makes up the majority of the site volume.

HTML Optimization

-87%

Potential reduce by 178.6 kB

  • Original 205.0 kB
  • After minification 165.8 kB
  • After compression 26.4 kB

HTML content can be minified and compressed by a website’s server. The most efficient way is to compress content using GZIP which reduces data amount travelling through the network between server and browser. This page needs HTML code to be minified as it can gain 39.3 kB, which is 19% of the original size. It is highly recommended that content of this web page should be compressed using GZIP, as it can save up to 178.6 kB or 87% of the original size.

Image Optimization

-14%

Potential reduce by 122.1 kB

  • Original 851.5 kB
  • After minification 729.4 kB

Image size optimization can help to speed up a website loading time. The chart above shows the difference between the size before and after optimization. Obviously, Drug Research Er needs image optimization as it can save up to 122.1 kB or 14% of the original volume. The most popular and efficient tools for JPEG and PNG image optimization are Jpegoptim and PNG Crush.

JavaScript Optimization

-57%

Potential reduce by 319.3 kB

  • Original 557.0 kB
  • After minification 556.8 kB
  • After compression 237.7 kB

It’s better to minify JavaScript in order to improve website performance. The diagram shows the current total size of all JavaScript files against the prospective JavaScript size after its minification and compression. It is highly recommended that all JavaScript files should be compressed and minified as it can save up to 319.3 kB or 57% of the original size.

CSS Optimization

-0%

Potential reduce by 32 B

  • Original 76.2 kB
  • After minification 76.2 kB
  • After compression 76.1 kB

CSS files minification is very important to reduce a web page rendering time. The faster CSS files can load, the earlier a page can be rendered. Drugresearcher.com has all CSS files already compressed.

Requests Breakdown

Number of requests can be reduced by 9 (12%)

Requests Now

73

After Optimization

64

  • AJAX
  • Images
  • JavaScript
  • CSS

The browser has sent 73 CSS, Javascripts, AJAX and image requests in order to completely render the main page of Drug Research Er. We recommend that multiple CSS and JavaScript files should be merged into one by each type, as it can help reduce assets requests from 10 to 1 for JavaScripts and as a result speed up the page load time.

Network Requests Diagram

drugresearcher.com

drugresearcher.com

191 ms

www.outsourcing-pharma.com

www.outsourcing-pharma.com

47 ms

OtAutoBlock.js

OtAutoBlock.js

64 ms

otSDKStub.js

otSDKStub.js

76 ms

css2

css2

69 ms

9fd7a26.css

9fd7a26.css

8 ms

52bd55a.css

52bd55a.css

30 ms

559e323.js

559e323.js

49 ms

gpt.js

gpt.js

454 ms

launch-d12cb4e80409.min.js

launch-d12cb4e80409.min.js

58 ms

e3f07a2.js

e3f07a2.js

41 ms

api.js

api.js

65 ms

hx4BqjQX.js

hx4BqjQX.js

56 ms

wrbm-footer.js

wrbm-footer.js

179 ms

a4059fed-897b-4db5-a82b-453e6acff63f.json

a4059fed-897b-4db5-a82b-453e6acff63f.json

104 ms

ps-bg.jpg

ps-bg.jpg

759 ms

9283791

9283791

77 ms

18449

18449

37 ms

icons.svg

icons.svg

36 ms

4362121

4362121

36 ms

Accelerated-FDA-approval-for-primary-biliary-cholangitis-treatment.jpg

Accelerated-FDA-approval-for-primary-biliary-cholangitis-treatment.jpg

284 ms

Ayvakit-drives-185-revenue-surge-in-2024-with-strong-global-growth.jpg

Ayvakit-drives-185-revenue-surge-in-2024-with-strong-global-growth.jpg

283 ms

2M-vaccines-ready-to-fight-mpox.jpg

2M-vaccines-ready-to-fight-mpox.jpg

285 ms

Tonix-Pharma-offers-hope-to-fibromyalgia-sufferers.jpg

Tonix-Pharma-offers-hope-to-fibromyalgia-sufferers.jpg

283 ms

Lonza-expands-manufacturing-with-bottling-and-labeling-at-US-site.jpg

Lonza-expands-manufacturing-with-bottling-and-labeling-at-US-site.jpg

287 ms

Women-in-Science-Almac-Diagnostic-Services-Katarina-Wikstrom.jpg

Women-in-Science-Almac-Diagnostic-Services-Katarina-Wikstrom.jpg

286 ms

FDA-approves-needle-free-epinephrine-nasal-spray-for-anaphylaxis.jpg

FDA-approves-needle-free-epinephrine-nasal-spray-for-anaphylaxis.jpg

287 ms

Women-in-Science-uMotif-s-chief-marketing-officer-Elaine-Maynard.jpg

Women-in-Science-uMotif-s-chief-marketing-officer-Elaine-Maynard.jpg

287 ms

Expert-insights-on-pharma-outsourcing-with-CluePoints.jpg

Expert-insights-on-pharma-outsourcing-with-CluePoints.jpg

286 ms

FDA-requests-more-trials-for-Lykos-PTSD-drug-approval.jpg

FDA-requests-more-trials-for-Lykos-PTSD-drug-approval.jpg

286 ms

Partnership-s-founding-of-institute-to-foster-therapeutic-innovation.jpg

Partnership-s-founding-of-institute-to-foster-therapeutic-innovation.jpg

290 ms

What-is-precision-psychiatry-Insights-from-Universal-Brain.jpg

What-is-precision-psychiatry-Insights-from-Universal-Brain.jpg

288 ms

Optimizing-medical-equipment-maintenance-strategies.jpg

Optimizing-medical-equipment-maintenance-strategies.jpg

289 ms

FDA-poised-to-decide-on-Lykos-MDMA-therapy-for-PTSD.jpg

FDA-poised-to-decide-on-Lykos-MDMA-therapy-for-PTSD.jpg

289 ms

Red-Queen-launches-to-tackle-viral-infections.jpg

Red-Queen-launches-to-tackle-viral-infections.jpg

290 ms

AI-tool-enhances-drug-discovery-for-age-related-diseases.jpg

AI-tool-enhances-drug-discovery-for-age-related-diseases.jpg

287 ms

Skye-and-Beacon-collaborate-on-sleep-apnea-in-obesity-trial.jpg

Skye-and-Beacon-collaborate-on-sleep-apnea-in-obesity-trial.jpg

330 ms

Strategies-for-CDMOs-to-prepare-for-the-2032-BioSecure-Act.jpg

Strategies-for-CDMOs-to-prepare-for-the-2032-BioSecure-Act.jpg

332 ms

Piramal-Pharma-Solutions-surpasses-revenue-milestone-in-innovation.jpg

Piramal-Pharma-Solutions-surpasses-revenue-milestone-in-innovation.jpg

332 ms

Oxford-experts-unveil-breakthrough-online-therapies-for-anxiety-and-PTSD.jpg

Oxford-experts-unveil-breakthrough-online-therapies-for-anxiety-and-PTSD.jpg

331 ms

Women-in-Science-Ann-Graham-from-fighting-cancer-to-helping-kids.jpg

Women-in-Science-Ann-Graham-from-fighting-cancer-to-helping-kids.jpg

331 ms

Bateman-Horne-Center-advances-ME-CFS-and-long-COVID-care.jpg

Bateman-Horne-Center-advances-ME-CFS-and-long-COVID-care.jpg

330 ms

2-Million-in-grants-awarded-to-tackle-neurodegenerative-diseases.jpg

2-Million-in-grants-awarded-to-tackle-neurodegenerative-diseases.jpg

337 ms

FDA-approves-Incyte-and-Syndax-s-Niktimvo-for-chronic-GVHD-treatment.jpg

FDA-approves-Incyte-and-Syndax-s-Niktimvo-for-chronic-GVHD-treatment.jpg

337 ms

FDA-lifts-hold-on-BioNTech-and-MediLink-s-ADC-trial.jpg

FDA-lifts-hold-on-BioNTech-and-MediLink-s-ADC-trial.jpg

336 ms

Sangamo-signs-agreement-with-Genentech-up-to-1.9BN-in-value.jpg

Sangamo-signs-agreement-with-Genentech-up-to-1.9BN-in-value.jpg

338 ms

CVC-Capital-buys-immunomodulatory-therapy-business-for-925-million.jpg

CVC-Capital-buys-immunomodulatory-therapy-business-for-925-million.jpg

336 ms

FDA-s-endorsement-brings-Amgen-and-AstraZeneca-closer-to-COPD-treatment.jpg

FDA-s-endorsement-brings-Amgen-and-AstraZeneca-closer-to-COPD-treatment.jpg

335 ms

PLAIO-secures-4.3M-to-expand-AI-pharma-planning-platform.jpg

PLAIO-secures-4.3M-to-expand-AI-pharma-planning-platform.jpg

352 ms

Harnessing-technology-for-a-new-era-in-drug-development.jpg

Harnessing-technology-for-a-new-era-in-drug-development.jpg

339 ms

Women-in-Science-Deep-Genomics-Tehmina-Masud.jpg

Women-in-Science-Deep-Genomics-Tehmina-Masud.jpg

337 ms

EU-rejects-lecanemab-for-Alzheimer-s-treatment.jpg

EU-rejects-lecanemab-for-Alzheimer-s-treatment.jpg

338 ms

UcCO3FwrK3iLTeHuS_nVMrMxCp50SjIw2boKoduKmMEVuI6fMZg.ttf

UcCO3FwrK3iLTeHuS_nVMrMxCp50SjIw2boKoduKmMEVuI6fMZg.ttf

348 ms

UcCO3FwrK3iLTeHuS_nVMrMxCp50SjIw2boKoduKmMEVuLyfMZg.ttf

UcCO3FwrK3iLTeHuS_nVMrMxCp50SjIw2boKoduKmMEVuLyfMZg.ttf

445 ms

UcCO3FwrK3iLTeHuS_nVMrMxCp50SjIw2boKoduKmMEVuGKYMZg.ttf

UcCO3FwrK3iLTeHuS_nVMrMxCp50SjIw2boKoduKmMEVuGKYMZg.ttf

512 ms

UcCO3FwrK3iLTeHuS_nVMrMxCp50SjIw2boKoduKmMEVuFuYMZg.ttf

UcCO3FwrK3iLTeHuS_nVMrMxCp50SjIw2boKoduKmMEVuFuYMZg.ttf

511 ms

location

location

324 ms

osp.png

osp.png

330 ms

WR_Monoblack_RGB.svg

WR_Monoblack_RGB.svg

667 ms

osp-logo-white.svg

osp-logo-white.svg

319 ms

osp-logo-white.svg

osp-logo-white.svg

316 ms

neolane_user_data

neolane_user_data

365 ms

active_popup_info

active_popup_info

71 ms

Cure51-co-founders-on-changing-cancer-treatment.jpg

Cure51-co-founders-on-changing-cancer-treatment.jpg

68 ms

Donanemab-approval-a-new-era-for-Alzheimer-s-treatment.jpg

Donanemab-approval-a-new-era-for-Alzheimer-s-treatment.jpg

76 ms

Women-in-Science-Ann-Graham-from-fighting-cancer-to-helping-kids.jpg

Women-in-Science-Ann-Graham-from-fighting-cancer-to-helping-kids.jpg

73 ms

Women-in-Science-Deep-Genomics-Tehmina-Masud.jpg

Women-in-Science-Deep-Genomics-Tehmina-Masud.jpg

74 ms

Women-in-Science-Neurologist-Suzanne-LeBlang-s-passion-for-patients.jpg

Women-in-Science-Neurologist-Suzanne-LeBlang-s-passion-for-patients.jpg

71 ms

Women-in-Science-Neurologist-Antonella-Favit-VanPelt.jpg

Women-in-Science-Neurologist-Antonella-Favit-VanPelt.jpg

70 ms

Caroline-Shleifer-Leading-AI-driven-regulatory-intelligence.jpg

Caroline-Shleifer-Leading-AI-driven-regulatory-intelligence.jpg

73 ms

Unlocking-innovation-Women-in-Science-Ketaki-Patwardhan.jpg

Unlocking-innovation-Women-in-Science-Ketaki-Patwardhan.jpg

155 ms

Women-in-Science-Vector-Labs-Pam-James.png

Women-in-Science-Vector-Labs-Pam-James.png

163 ms

Women-In-Science-Lonza-s-Inbar-Friedrich-Ben-Nun.png

Women-In-Science-Lonza-s-Inbar-Friedrich-Ben-Nun.png

158 ms

Women-in-Science-Maryam-Abdul-Kareem-from-lab-technician-to-law.png

Women-in-Science-Maryam-Abdul-Kareem-from-lab-technician-to-law.png

156 ms

Women-in-Science-Stella-Vnook-the-importance-of-resilience-and-persistence.jpg

Women-in-Science-Stella-Vnook-the-importance-of-resilience-and-persistence.jpg

162 ms

Women-in-Science-this-week-Orla-Cussen.jpg

Women-in-Science-this-week-Orla-Cussen.jpg

163 ms

Pam-Diamond-The-Sound-of-Medicine.jpg

Pam-Diamond-The-Sound-of-Medicine.jpg

225 ms

From-ninth-grade-biology-to-the-STEM-industry-Courtney-Noah-s-journey.jpg

From-ninth-grade-biology-to-the-STEM-industry-Courtney-Noah-s-journey.jpg

188 ms

From-banking-to-biotech-Renee-Aguiar-Lucander-s-unique-path-in-science.jpg

From-banking-to-biotech-Renee-Aguiar-Lucander-s-unique-path-in-science.jpg

186 ms

Women-in-Science-Wednesday-Karen-Ooms-journey-to-Quanticate.jpg

Women-in-Science-Wednesday-Karen-Ooms-journey-to-Quanticate.jpg

185 ms

Women-in-Science-Katrina-Rice-on-making-the-world-a-little-better.png

Women-in-Science-Katrina-Rice-on-making-the-world-a-little-better.png

184 ms

Women-in-Science-Elisa-Cascade-on-why-women-should-never-be-afraid-to-ask.png

Women-in-Science-Elisa-Cascade-on-why-women-should-never-be-afraid-to-ask.png

185 ms

Accessibility Review

drugresearcher.com accessibility score

100

Accessibility Issues

Best Practices

drugresearcher.com best practices score

75

Areas of Improvement

Trust and Safety

Impact

Issue

High

Does not use HTTPS

High

Includes front-end JavaScript libraries with known security vulnerabilities

Low

Ensure CSP is effective against XSS attacks

User Experience

Impact

Issue

High

Serves images with low resolution

General

Impact

Issue

Low

Detected JavaScript libraries

High

Page has valid source maps

SEO Factors

drugresearcher.com SEO score

93

Search Engine Optimization Advices

Content Best Practices

Format your HTML in a way that enables crawlers to better understand your app’s content.

Impact

Issue

High

Links do not have descriptive text

Mobile Friendly

Make sure your pages are mobile friendly so users don’t have to pinch or zoom in order to read the content pages. [Learn more](https://developers.google.com/search/mobile-sites/).

Impact

Issue

High

Document uses legible font sizes

Language and Encoding

  • Language Detected

    EN

  • Language Claimed

    EN

  • Encoding

    UTF-8

Language claimed in HTML meta tag should match the language actually used on the web page. Otherwise Drugresearcher.com can be misinterpreted by Google and other search engines. Our service has detected that English is used on the page, and it matches the claimed language. Our system also found out that Drugresearcher.com main page’s claimed encoding is utf-8. Use of this encoding format is the best practice as the main page visitors from all over the world won’t have any issues with symbol transcription.

Social Sharing Optimization

drugresearcher.com

Open Graph description is not detected on the main page of Drug Research Er. Lack of Open Graph description can be counter-productive for their social media presence, as such a description allows converting a website homepage (or other pages) into good-looking, rich and well-structured posts, when it is being shared on Facebook and other social media. For example, adding the following code snippet into HTML <head> tag will help to represent this web page correctly in social networks: